Lorazepam-d4 (CRM)

Lorazepam-d4 (CRM) (Cay-18728) is intended for use as an internal standard for the quantification of lorazepam (Cay-ISO60202, Cay-15891) by GC- or LC-MS. Lorazepam is categorized as a benzodiazepine. It has anxiolytic properties and is a metabolite of diclazepam (Cay-28623, Cay-15554). Formulations containing lorazepam have been used in the treatment of anxiety. Lorazepam-d4 is regulated as a Schedule IV compound in the United States. Lorazepam-d4 (CRM) (Cay-18728) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.Formal Name: 7-chloro-5-(6-chlorophenyl-2,3,4,5-d4)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one. CAS Number: 84344-15-0. Molecular Formula: C15H6Cl2D4N2O2. Formula Weight: 325.2. Formulation: (Request formulation change), A 100 µg/ml solution in acetonitrile. SMILES: ClC1=C([2H])C([2H])=C([2H])C([2H])=C1C(C(C=C(Cl)C=C2)=C2N3)=NC(O)C3=O. InChi Code: InChI=1S/C15H10Cl2N2O2/c16-8-5-6-12-10(7-8)13(19-15(21)14(20)18-12)9-3-1-2-4-11(9)17/h1-7,15,21H,(H,18,20)/i1D,2D,3D,4D. InChi Key: DIWRORZWFLOCLC-RHQRLBAQSA-N.